rs150926439
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_005142.3(CBLIF):c.910C>T(p.Pro304Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,614,168 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005142.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBLIF | NM_005142.3 | c.910C>T | p.Pro304Ser | missense_variant | 7/9 | ENST00000257248.3 | NP_005133.2 | |
CBLIF | XM_011544939.4 | c.868C>T | p.Pro290Ser | missense_variant | 7/9 | XP_011543241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBLIF | ENST00000257248.3 | c.910C>T | p.Pro304Ser | missense_variant | 7/9 | 1 | NM_005142.3 | ENSP00000257248.2 |
Frequencies
GnomAD3 genomes AF: 0.000867 AC: 132AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000943 AC: 237AN: 251432Hom.: 0 AF XY: 0.00102 AC XY: 139AN XY: 135886
GnomAD4 exome AF: 0.00114 AC: 1670AN: 1461856Hom.: 5 Cov.: 32 AF XY: 0.00117 AC XY: 849AN XY: 727236
GnomAD4 genome AF: 0.000867 AC: 132AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000832 AC XY: 62AN XY: 74478
ClinVar
Submissions by phenotype
Hereditary intrinsic factor deficiency Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 18, 2021 | The c.910C>T (p.P304S) alteration is located in exon 7 (coding exon 7) of the GIF gene. This alteration results from a C to T substitution at nucleotide position 910, causing the proline (P) at amino acid position 304 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
CBLIF-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 02, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at